Oral Oncol:口腔HPV感染可致头颈癌

2015-03-02 MedSci MedSci原创

Oral Oncol:口腔HPV感染可致头颈癌关键词:头颈癌 HPV 口咽癌引言目前全世界最常见的病毒感染史人乳头瘤病毒(HPV)感染,感染了至少6亿3千万人。HPV至少有150种不同的病毒株,其中一些是致癌的(HPV16和HPV18),可能与生殖器癌和口腔癌有关。首次提出HPV与口咽癌相关是在30年前,HPV不再认为是口咽癌的危险因素而是口咽癌的发病因素。在发达国家,包括美国,HPV至少和90%

引言

目前全世界最常见的病毒感染史人乳头瘤病毒(HPV)感染,感染了至少6亿3千万人。HPV至少有150种不同的病毒株,其中一些是致癌的(HPV16和HPV18),可能与生殖器癌和口腔癌有关。首次提出HPV与口咽癌相关是在30年前,HPV不再认为是口咽癌的危险因素而是口咽癌的发病因素。在发达国家,包括美国,HPV至少和90%以上的口咽癌相关。据统计,在美国,大多数性行为活跃的成年人在其一生中都会感染HPV。

通常认为头颈癌(HNC)与吸烟喝酒有关,高达75%的头颈癌病例与这些因素有关。然而,研究表明,吸烟喝酒所致的头颈癌正在减少,而HPV相关性头颈癌,特别是口咽癌,正在增加。实际上,1980s以来HPV阴性的头颈癌(与吸烟喝酒有关)其发病率下降了50%,而HPV阳性的头颈癌其发病率增加了225%。与烟草所致的HNCs(主要发生在60岁以上人群)不同,口咽癌好发在60岁以下的人群而且很多病例显示这些患者无吸烟喝酒史。

HPV相关性口咽癌的主要危险因素是口腔HPV感染,口腔HPV感染主要是通过性传播,相关的性行为包括早期性交、多性伴侣、口交以及舌吻(HPV感染发生率相对较小)。文献记载的其他的危险行为还包括性别和吸烟等。男性患HPV相关性口咽癌的患病率约为女性的二倍,吸烟可能会增加患口咽癌的几率,因为香烟中含有诱变剂和致癌物。目前正在使用HPV疫苗来预防HPV病毒株,尤其是HPV16和HPV18,引起的头颈、肛门和生殖器癌。几乎所有的头颈癌都能发现HPV16和HPV18,尤其是HPV16。

尽管HPV疫苗并未推荐用来预防口腔HPV感染,哥斯达黎加的一个临床试验表明HPV疫苗在预防HPV16和HPV18感染100%有效。然而,面对着HPV阳性的口腔癌发病率不断升高,HPV疫苗接种率仍然不理想。其中一个原因是由于对HPV疫苗,HPV以及HPV与头颈癌的关系了解甚少。唯一的一个已知研究是在美国东南部女性为主的白种人中调查了当地人对于HPV与HNC关系的了解。然而,相比于女性,口腔HPV感染与口咽癌在男性则更为普遍。

本研究的目的是为了评估人群对HPV疫苗、HPV和HPV与HNC的了解水平,以及这些知识水平与性行为习惯、危险性行为、和以男性为主的非洲裔美国人群的风险认知之间的关系。本研究也对目标人群HPV感染来源进行了表征。本研究的样本大部分是非洲裔美国人,相比于白种人,其头颈癌死亡的危险性较高。

摘要

目的:为了了解HPV,以及HPV与头颈癌(HNC)的关系以及高危人群对HPV的认识。

材料和方法:横断面调查2013年东圣路易斯飙车人员。

结果:只有29.9%的人知道HPV会增加患HNC的风险,42.4%的人认为HPV与HIV一样,只有25.1%的人从保健医师那了解过HPV。认为性伴侣数目没有增加患HPV的风险的研究对象对HPV的了解得分较低(r=0.74,p<0.001)。这与对HNC知识、性伴侣数目、初次性交年龄以及对危险因素的了解之间具有显著地关系;那些认为性伴侣数目多不会增加HPV感染几率的人员得分较低的概率增加33倍(OR=33.27;95% cl:16.34,64.74)。

结论:对HPV以及HPV与HNC的关系的了解在这一人群中具有显著地差异。

原始出处:

Osazuwa-Peters N, Wang DD, Namin A, Vivek J, O'Neill M, Patel PV, Varvares MA.Sexual behavior, HPV knowledge, and association with head and neck cancer among a high-risk group.Oral Oncol. 2015 Feb 12. pii: S1368-8375(15)00023-8. doi: 10.1016/j.oraloncology.2015.01.011.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=125403, encodeId=4e9a12540352, content=好文章,还会关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Sep 13 14:35:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864617, encodeId=39de186461e08, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Mon Sep 28 21:05:00 CST 2015, time=2015-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23739, encodeId=6bbe23e3943, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020156, encodeId=11e220201560f, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Thu Apr 09 18:05:00 CST 2015, time=2015-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295864, encodeId=c8c31295864a4, content=<a href='/topic/show?id=f30a4441598' target=_blank style='color:#2F92EE;'>#头颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44415, encryptionId=f30a4441598, topicName=头颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483029, encodeId=11d6148302918, content=<a href='/topic/show?id=0ac39080cc' target=_blank style='color:#2F92EE;'>#HPV感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9080, encryptionId=0ac39080cc, topicName=HPV感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56437868203, createdName=ms3415360956839622, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17483, encodeId=05581e483ed, content=洁身自好最安全, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Tue Mar 03 12:37:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
    2016-09-13 1e10c84am36(暂无匿称)

    好文章,还会关注

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=125403, encodeId=4e9a12540352, content=好文章,还会关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Sep 13 14:35:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864617, encodeId=39de186461e08, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Mon Sep 28 21:05:00 CST 2015, time=2015-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23739, encodeId=6bbe23e3943, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020156, encodeId=11e220201560f, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Thu Apr 09 18:05:00 CST 2015, time=2015-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295864, encodeId=c8c31295864a4, content=<a href='/topic/show?id=f30a4441598' target=_blank style='color:#2F92EE;'>#头颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44415, encryptionId=f30a4441598, topicName=头颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483029, encodeId=11d6148302918, content=<a href='/topic/show?id=0ac39080cc' target=_blank style='color:#2F92EE;'>#HPV感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9080, encryptionId=0ac39080cc, topicName=HPV感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56437868203, createdName=ms3415360956839622, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17483, encodeId=05581e483ed, content=洁身自好最安全, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Tue Mar 03 12:37:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
    2015-09-28 minlingfeng
  3. [GetPortalCommentsPageByObjectIdResponse(id=125403, encodeId=4e9a12540352, content=好文章,还会关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Sep 13 14:35:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864617, encodeId=39de186461e08, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Mon Sep 28 21:05:00 CST 2015, time=2015-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23739, encodeId=6bbe23e3943, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020156, encodeId=11e220201560f, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Thu Apr 09 18:05:00 CST 2015, time=2015-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295864, encodeId=c8c31295864a4, content=<a href='/topic/show?id=f30a4441598' target=_blank style='color:#2F92EE;'>#头颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44415, encryptionId=f30a4441598, topicName=头颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483029, encodeId=11d6148302918, content=<a href='/topic/show?id=0ac39080cc' target=_blank style='color:#2F92EE;'>#HPV感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9080, encryptionId=0ac39080cc, topicName=HPV感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56437868203, createdName=ms3415360956839622, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17483, encodeId=05581e483ed, content=洁身自好最安全, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Tue Mar 03 12:37:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
    2015-05-16 ljjj1053

    很不错学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=125403, encodeId=4e9a12540352, content=好文章,还会关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Sep 13 14:35:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864617, encodeId=39de186461e08, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Mon Sep 28 21:05:00 CST 2015, time=2015-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23739, encodeId=6bbe23e3943, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020156, encodeId=11e220201560f, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Thu Apr 09 18:05:00 CST 2015, time=2015-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295864, encodeId=c8c31295864a4, content=<a href='/topic/show?id=f30a4441598' target=_blank style='color:#2F92EE;'>#头颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44415, encryptionId=f30a4441598, topicName=头颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483029, encodeId=11d6148302918, content=<a href='/topic/show?id=0ac39080cc' target=_blank style='color:#2F92EE;'>#HPV感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9080, encryptionId=0ac39080cc, topicName=HPV感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56437868203, createdName=ms3415360956839622, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17483, encodeId=05581e483ed, content=洁身自好最安全, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Tue Mar 03 12:37:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
    2015-04-09 小几洁
  5. [GetPortalCommentsPageByObjectIdResponse(id=125403, encodeId=4e9a12540352, content=好文章,还会关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Sep 13 14:35:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864617, encodeId=39de186461e08, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Mon Sep 28 21:05:00 CST 2015, time=2015-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23739, encodeId=6bbe23e3943, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020156, encodeId=11e220201560f, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Thu Apr 09 18:05:00 CST 2015, time=2015-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295864, encodeId=c8c31295864a4, content=<a href='/topic/show?id=f30a4441598' target=_blank style='color:#2F92EE;'>#头颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44415, encryptionId=f30a4441598, topicName=头颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483029, encodeId=11d6148302918, content=<a href='/topic/show?id=0ac39080cc' target=_blank style='color:#2F92EE;'>#HPV感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9080, encryptionId=0ac39080cc, topicName=HPV感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56437868203, createdName=ms3415360956839622, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17483, encodeId=05581e483ed, content=洁身自好最安全, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Tue Mar 03 12:37:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=125403, encodeId=4e9a12540352, content=好文章,还会关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Sep 13 14:35:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864617, encodeId=39de186461e08, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Mon Sep 28 21:05:00 CST 2015, time=2015-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23739, encodeId=6bbe23e3943, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020156, encodeId=11e220201560f, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Thu Apr 09 18:05:00 CST 2015, time=2015-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295864, encodeId=c8c31295864a4, content=<a href='/topic/show?id=f30a4441598' target=_blank style='color:#2F92EE;'>#头颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44415, encryptionId=f30a4441598, topicName=头颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483029, encodeId=11d6148302918, content=<a href='/topic/show?id=0ac39080cc' target=_blank style='color:#2F92EE;'>#HPV感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9080, encryptionId=0ac39080cc, topicName=HPV感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56437868203, createdName=ms3415360956839622, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17483, encodeId=05581e483ed, content=洁身自好最安全, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Tue Mar 03 12:37:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=125403, encodeId=4e9a12540352, content=好文章,还会关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Tue Sep 13 14:35:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864617, encodeId=39de186461e08, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Mon Sep 28 21:05:00 CST 2015, time=2015-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23739, encodeId=6bbe23e3943, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020156, encodeId=11e220201560f, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Thu Apr 09 18:05:00 CST 2015, time=2015-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295864, encodeId=c8c31295864a4, content=<a href='/topic/show?id=f30a4441598' target=_blank style='color:#2F92EE;'>#头颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44415, encryptionId=f30a4441598, topicName=头颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483029, encodeId=11d6148302918, content=<a href='/topic/show?id=0ac39080cc' target=_blank style='color:#2F92EE;'>#HPV感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9080, encryptionId=0ac39080cc, topicName=HPV感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56437868203, createdName=ms3415360956839622, createdTime=Wed Mar 04 11:05:00 CST 2015, time=2015-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17483, encodeId=05581e483ed, content=洁身自好最安全, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ixiaochengdudu, createdTime=Tue Mar 03 12:37:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
    2015-03-03 ixiaochengdudu

    洁身自好最安全

    0

相关资讯

Nature:科学家提出头颈癌治疗新思路

目前头颈部的鳞状细胞癌(HNSCC)是美国最为普遍的10种癌症之一,尽管其非常流行,但研究人员对其的发病及扩散的机制却是知之甚少,近日,一篇刊登在国际著名杂志Nature上的一篇研究论文中,来自耶鲁大学医学院的研究人员就为揭示头颈癌的发病机制提供了重要的信息。头颈癌是由一种名为人乳头瘤病毒(HPV)的病毒引发的,利用来自HPV阳性和阴性患者的肿瘤组织,研究人员就对其发生的突变或致癌基因进行了全面的

Nature杂志发表头颈癌基因组测序结果

Nature杂志1月28日发表了迄今为止最全面的头颈癌基因组测序分析结果。癌症基因组图谱计划(Cancer Genome Atlas,TCGA)的科学家们揭示了人乳头瘤病毒(HPV)和抽烟对头颈癌的影响,比较了头颈癌与其它癌症的异同,为头颈癌的诊断和治疗提供了新的方向。 HPV是美国最常见的性传播病毒之一,HPV引发的头颈癌正在逐年增加。FDA批准的HPV疫苗能够预防HPV感染,但病毒感染与癌症

JCO:Tax-PF诱导化疗治疗局部晚期头颈癌结局较好

部分针对局部晚期头颈癌(LAHNC)进行的随机试验曾对顺铂-氟尿嘧啶(PF)诱导化疗方案与紫杉类(多西他赛或紫杉醇)、顺铂及氟尿嘧啶(Tax-PF)方案进行过比较。在2013年7月8日在线出版的《临床肿瘤学杂志》(Journal of Clinical Oncology)上,法国古斯塔夫·鲁西研究所Jean-Pierre Pignon博士等人对相关研究进行了一项荟萃分析,该分析对Tax-PF与PF

Cancer:CCTα或可头颈癌和非小细胞肺癌的新生物标志物

ERCC1(DNA切除修复交叉互补基因1)蛋白表达是非小细胞肺癌患者辅助化疗的疗效预测标志物,8F1是目前最常用于测定测定肺癌患者组织中ERCC1表达水平的单克隆抗体之一。由佛罗里达大学斯克里普斯研究所(TSRI)的科学家带领的一个研究小组曾经指出,8F1可识别另一种核抗原,这种抗原具有作为临床预后分析生物标志物的价值。目前,该研究小组确定了这种新的生物标志物,与头颈癌和非小细胞肺癌患者的较好预后

读懂HPV:癌症防治新抓手

对HPV的新认识能够帮助医生治疗癌症,并最终依靠疫苗有效防治癌症。         人乳头瘤病毒在透射电子显微镜下的形态。         图片来源:PASIEKA MauraGillison漫步在美国约翰斯·霍普

多塞平可缓解头颈癌患者口腔痛

    最近一项研究发现,对于接受放疗的头颈癌患者,抗抑郁药多塞平可减轻其口腔粘膜的炎症引起的相关疼痛。   “口腔粘膜炎或口腔溃疡是一种放疗相关副作用,引起患者疼痛。”研究主要负责者、梅奥诊所放射肿瘤学家也是罗伯特?米勒说,“我们的发现为这种情况的治疗提供了新的应对标准。”   该项三期临床试验共纳入155例接受放疗的头颈癌患者,随机分为多塞平口腔灌洗组和安慰剂组,并对疗效进行评